Genetic Polymorphism and Israeli Top-level Swimmers' Performance and Expertise
NCT ID: NCT01319032
Last Updated: 2011-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2011-04-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research for Individualized Therapeutics in Rare Genetic Disease
NCT05236595
Genetic Collection Protocol
NCT05272319
Genetics of Cardiovascular and Neuromuscular Disease
NCT00138931
Clinical Implementation of Carrier Status Using Next Generation Sequencing
NCT01902901
Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder
NCT01452061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I. Top-level swimmers
Extraction of whole blood
Extraction of DNA from whole blood
II. Control
Other swimmers
Extraction of whole blood
Extraction of DNA from whole blood
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extraction of whole blood
Extraction of DNA from whole blood
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Other swimmers
Exclusion Criteria
13 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wingate Institute
OTHER
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hillel Yaffe Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wingate Institute
Netanya, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Sigal Ben Zaken, PhD
Role: CONTACT
References
Explore related publications, articles, or registry entries linked to this study.
Ben-Zaken S, Eliakim A, Nemet D, Rabinovich M, Kassem E, Meckel Y. ACTN3 Polymorphism: Comparison Between Elite Swimmers and Runners. Sports Med Open. 2015;1(1):13. doi: 10.1186/s40798-015-0023-y. Epub 2015 Jun 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0013-11-HYMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.